Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term randomized double-blind trial of Stalevo versus carbidopa/levodopa in Parkinson's disease initiating levodopa
2004-000185-12Phase 3Completed
- Sponsor
- Orion Corporation
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Orion Corporation. Primary endpoint: Time to onset of dyskinesia. Started Jul 2004; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-000185-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000185-12.